Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study | Journal of Clinical Oncology
Simplifying the Derivation of Best Overall Response per RECIST 1.1 and iRECIST in Solid Tumor Clinical Studies
Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study | Leukemia
Best Overall Response Rate to Treatment | Download Table
Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study | SpringerLink
ORR (Objective Response Rate) and related statistics – Part 1
Best Overall Response Rate (full analysis population) | Download Table
Best overall response rate and clinical benefit rate for patients with... | Download Scientific Diagram
Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1) | British Journal of Cancer
Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study | SpringerLink
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
EPOCH trial - Boston Scientific
Response rate of anticancer drugs approved by the Food and Drug Administration based on a single-arm trial | BMC Cancer | Full Text
Efficacy endpoints in Oncology
Best Overall Response per Response Evaluation Criteria in Solid | Download Scientific Diagram
Disease Response Swimmer Plot
Zacks Small Cap Research - ONCS: New Data Provide Evidence that ImmunoPulse IL-12 Can Prime the Immune System
Best overall tumor response and objective response rate | Download Table
Best Overall Response per irRC by Investigator Assessment | Download Table
Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study | Journal of Clinical Oncology
Durable Responses Are Observed With Cemiplimab in mBCC
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
